Clinical trial
A Study on the Anti-proteinuric Effects of Pioglitazone in Patients With Type 2 Diabetes.
NCT00749047 is registered in ClinicalTrials.gov with Christchurch Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study on the Anti-proteinuric Effects of Pioglitazone in Patients With Type 2 Diabetes.
- Lead sponsor
- Christchurch Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2008
- Completion date
- March 31, 2010
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.